Povidone-Iodine 0.3% — Competitive Intelligence Brief

Povidone-Iodine 0.3% (Povidone-Iodine 0.3%) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Topical antiseptic/disinfectant. Area: Infectious Disease / Dermatology.

marketed Topical antiseptic/disinfectant Infectious Disease / Dermatology Small molecule

Target snapshot

Povidone-Iodine 0.3% (Povidone-Iodine 0.3%) — Norwegian University of Science and Technology. Povidone-iodine is a broad-spectrum antimicrobial agent that releases iodine to disrupt microbial cell membranes and proteins, killing bacteria, viruses, fungi, and protozoa.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Povidone-Iodine 0.3% TARGET	Povidone-Iodine 0.3%	Norwegian University of Science and Technology	marketed	Topical antiseptic/disinfectant
propan-2-ol	propan-2-ol	The Hong Kong Polytechnic University	marketed	Topical antiseptic/disinfectant
Iodophor (10% povidone-iodine)	Iodophor (10% povidone-iodine)	University of California, Irvine	marketed	Topical antiseptic/disinfectant
Iodophor 0.7% and IPA 74% w/w	Iodophor 0.7% and IPA 74% w/w	Johns Hopkins University	marketed	Topical antiseptic/disinfectant
Povidone-iodine irrigation	Povidone-iodine irrigation	Corewell Health East	marketed	Topical antiseptic/disinfectant
Povidone Iodine Topical	Povidone Iodine Topical	Mary K Hayden	marketed	Topical antiseptic/disinfectant	Microbial cell membranes and proteins (non-selective)
Lugols Strong Iodine	Lugols Strong Iodine	Jesús María Villar del Moral	marketed	Topical antiseptic/disinfectant	Microbial proteins and nucleic acids (non-specific oxidative mechanism)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Topical antiseptic/disinfectant class)

1. Corewell Health East · 1 drug in this class
2. Jesús María Villar del Moral · 1 drug in this class
3. Johns Hopkins University · 1 drug in this class
4. Mary K Hayden · 1 drug in this class
5. Montefiore Medical Center · 1 drug in this class
6. Norwegian University of Science and Technology · 1 drug in this class
7. The Hong Kong Polytechnic University · 1 drug in this class
8. University of California, Irvine · 1 drug in this class
9. University of California, Los Angeles · 1 drug in this class